Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors

Chen, C. Y. C. (2008). Discovery of Novel Inhibitors for c-Met by Virtual Screening and Pharmacophore Analysis. Journal of the Chinese Institute of Chemical Engineers, 39(6), 617-624. https://www.airitilibrary.com/Article/Detail?DocID=03681653-200811-39-6-617-624-a
陳彥甫（2010）。A study for predicting protein-ligand binding modes and characterizing protein-ligand binding sites in structure-based drug design〔博士論文，國立交通大學〕。華藝線上圖書館。https://doi.org/10.6842/NCTU.2010.01062
黃文鑫、李安榮、謝永宏、簡培喻、楊巧麗（2001）。Pharmacological Action, Structural Modification and Drug Design of Leflunomide as Novel Immunosuppresants。Journal of Medical Sciences，21(S)，27-38。https://www.airitilibrary.com/Article/Detail?DocID=10114564-200111-201404220003-201404220003-27-38
Chou, W. Y. (2011). Prediction and analysis of in silico structure and ligand-binding residue for carbohydrate binding module [doctoral dissertation, National Tsing Hua University]. Airiti Library. https://doi.org/10.6843/NTHU.2011.00515
莊祐仲（2007）。A ligand-based molecular modeling study on a series of tyrosinase Inhibitors using 3D-QSAR CoMFA and CoMSIA〔碩士論文，亞洲大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0118-0807200916271550